Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_assertion type Assertion NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_head.
- NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_assertion description "[In vivo Grb7 peptide inhibitor statistically significantly attenuated cell migration (for control peptide, 87.5 cells migrated, 95% confidence interval [CI] = 82.6 to 92.4 cells; for Grb7 peptide, 5.7 cells migrated, 95% CI = 2.3 to 9.0 cells; P < .001) and peritoneal metastasis of the pancreatic cancer cells in a mouse model, as assessed by the number of nodules (control = 72.6 nodules, 95% CI = 55.8 to 89.4 nodules; and for Grb7 peptide = 3.2 nodules, 95% CI = 1.6 to 4.8 nodules; P < .001, t test) and their weight (control = 4.13 g, 95% CI = 3.40 to 4.86 g; Grb7 peptide = 0.19 g, 95% CI = 0.06 to 0.32 g; P < .001, t test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_provenance.
- NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_assertion evidence source_evidence_literature NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_provenance.
- NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_assertion SIO_000772 16595785 NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_provenance.
- NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_assertion wasDerivedFrom befree-20150227 NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_provenance.
- NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_assertion wasGeneratedBy ECO_0000203 NP433608.RADBEyAtUOUb0w1CKx7zizWXB38q18aJk0TocI1laZcKw130_provenance.